Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :24078029
Publication Date : //

Simultaneous disruption of estrogen receptor and Wnt/β-catenin signaling is involved in methyl amooranin-mediated chemoprevention of mammary gland carcinogenesis in rats.


Methyl-amoorain (methyl-25-hydroxy-3-oxoo-lean-12-en-28-oate, AMR-Me), a novel synthetic oleanane triterpenoid, exerts a striking chemopreventive effect against 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumorigenesis through antiproliferative and proapoptotic actions. Nevertheless, the underlying mechanisms of action remain to be established. As estrogen receptor (ER) and canonical Wnt/b-catenin signaling are involved in the development and progression of breast cancer, the current study was designed to investigate the effects of AMR-Me treatment on the expressions of ER-a, ER-b, b-catenin and cyclin D1 in rat mammary tumors induced by DMBA. Mammary tumor samples were harvested from an 18-week chemopreventive study in which AMR-Me (0.8–1.6 mg/kg) was shown to inhibit mammary carcinogenesis in a dose–response manner. The expressions of ER-a, ER-b, b-catenin, and cyclin D1 were determined by immunohistochemistry and reverse transcription-polymerase chain reaction. AMR-Me downregulated the expression of intratumor ER-a and ER-b and lowered the ratio of ER-a to ER-b. AMR-Me also reduced the expression, cytoplasmic accumulation, and nuclear translocation of b-catenin, the essential transcriptional cofactor for Wnt signaling. Furthermore, AMR-Me modulated the expression of cell growth regulatory gene cyclin D1, which is a downstream target for both ER and Wnt signaling. AMR-Me at 1.6 mg/kg for 18 weeks did not exhibit any hepatotoxicity or renotoxicity. The results of the present study coupled with our previous findings indicate that simultaneous disruption of ER and Wnt/b-catenin signaling possibly contributes to antiproliferative and apoptosis-inducing effects implicated in AMR-Me-mediated chemoprevention of DMBA-induced breast tumorigenesis in rats. Our results also suggest a possible crosstalk between two key regulatory pathways, namely ER and Wnt/b-catenin signaling, involved in mammary carcinogenesis and the value of simultaneously targeting these pathways to achieve breast cancer chemoprevention.

Authors : Mandal Animesh , Bhatia Deepak , Bishayee Anupam ,

Related products :

Catalog number Product name Quantity
26-210 LAX1 is a single-pass type III membrane protein. It negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and BCR (B-cell antigen receptor)-mediated signaling in B-cells. 0.05 mg
26-285 OPRT (UMPS) is involved in early events of pancreatic and gallbladder carcinogenesis and invasion of hepatocellular carcinomas. Orotate phosphoribosyltransferase is involved in the invasion and metast 0.05 mg
MT-414-N7 Mouse Mammary Gland Total protein Mammary Gland, Day 7 of involution  0.5mg
MT-414-11 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E11  0.5mg
MT-414-13 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E13 0.5mg
MT-414-14 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E14 0.5mg
MT-414-15 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E15 0.5mg
MT-414-16 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E16  0.5mg
MT-414-18 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E18  0.5mg
MT-414-L1 Mouse Mammary Gland Total protein Mammary Gland, Day 1 of Lactation  0.5mg
MT-414-L3 Mouse Mammary Gland Total protein Mammary Gland, Day 3 of Lactation  0.5mg
MT-414-L7 Mouse Mammary Gland Total protein Mammary Gland, Day 7 of Lactation  0.5mg
MT-414-N1 Mouse Mammary Gland Total protein Mammary Gland, Day 1 of involution  0.5mg
MT-414-10 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E10   0.5mg
MT-414 Mouse Mammary Gland Total protein Mammary Gland, non pregnant 0.5mg
MT-414-12 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E12 0.5mg
MT-414-17 Mouse Mammary Gland Total protein Mammary Gland, pregnant_E17  0.5mg
RT-414-N7 Rat Mammary Gland Total protein Mammary Gland, Day 7 of involution  0.5mg
RT-414-15 Rat Mammary Gland Total protein Mammary Gland, pregnant_E15 0.5mg
RT-414-16 Rat Mammary Gland Total protein Mammary Gland, pregnant_E16  0.5mg
RT-414-17 Rat Mammary Gland Total protein Mammary Gland, pregnant_E17  0.5mg
RT-414 Rat Mammary Gland Total protein Mammary Gland, non pregnant 0.5mg
RT-414-13 Rat Mammary Gland Total protein Mammary Gland, pregnant_E13 0.5mg
RT-414-20 Rat Mammary Gland Total protein Mammary Gland, pregnant_E20  0.5mg
RT-414-L1 Rat Mammary Gland Total protein Mammary Gland, Day 1 of Lactation  0.5mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur